The once-daily human GLP-1 analogue liraglutide improves both absolute and baseline corrected postprandial glucose levels

被引：0

作者：

Flint, A. ^{[1
]}

Kapitza, C. ^{[2
]}

Hindsberger, C. ^{[1
]}

Zdravkovic, M. ^{[1
]}

机构：

[1] Novo Nordisk AS, Global Dev, DK-2880 Bagsvaerd, Denmark

[2] Profil Inst Stoffivechselforsch GmbH, Neuss, Germany

来源：

DIABETOLOGIA | 2008年 / 51卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

887

引用

页码：S354 / S354

页数：1

共 50 条

[1] The once-daily human GLP-1 analogue liraglutide improves both absolute and baseline corrected postprandial glucose levels
Flint, Anne
Kapitza, Christoph
Hindsberger, Charlotte
Zdravkovic, Milan
DIABETES, 2008, 57 : A165 - A165
[2] The once-daily human GLP-1 analogue liraglutide decreases postprandial hunger and energy intake
Flint, Anne
Kapitza, Christoph
Hinds-Berger, Charlotte
Zdravkovic, Milan
DIABETES, 2008, 57 : A165 - A165
[3] The effect of the once-daily human GLP-1 analogue liraglutide on the pharmacokinetics of paracetamol
Kapitza, Christoph
Flint, Anne
Hindsberger, Charlotte
Zdravkovic, Milan
DIABETES, 2008, 57 : A593 - A593
[4] Molecular, pharmacological and clinical aspects of liraglutide, a once-daily human GLP-1 analogue
Russell-Jones, David
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2009, 297 (1-2) : 137 - 140
[5] The once-daily human glucagon-like peptide-1 (GLP-1) analog liraglutide improves postprandial glucose levels in type 2 diabetes patients
Anne Flint
Christoph Kapitza
Charlotte Hindsberger
Milan Zdravkovic
Advances in Therapy, 2011, 28 : 213 - 226
[6] The Once-Daily Human Glucagon-Like Peptide-1 (GLP-1) Analog Liraglutide Improves Postprandial Glucose Levels in Type 2 Diabetes Patients
Flint, Anne
Kapitza, Christoph
Hindsberger, Charlotte
Zdravkovic, Milan
ADVANCES IN THERAPY, 2011, 28 (03) : 213 - 226
[7] Mechanism of Protraction for Liraglutide, the Once-Daily Human GLP-1 Analog
Knudsen, Lotte B.
Nielsen, Per F.
Steensgaard, Dorte B.
Bloch, Paw
Lau, Jesper
Agersoe, Henrik
DIABETES, 2009, 58 : A532 - A532
[8] Liraglutide: a once-daily GLP-1 analogue for the treatment of Type 2 diabetes mellitus
Vilsboll, Tina
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2007, 16 (02) : 231 - 237
[9] The effect of three different injection sites on the pharmacokinetics of the once-daily human GLP-1 analogue liraglutide
Kapitza, Christoph
Flint, Anne
Spitzer, Heike
Hindsberger, Charlotte
Zdravkovic, Milan
DIABETES, 2008, 57 : A593 - A593
[10] Effect of Three Different Injection Sites on the Pharmacokinetics of the Once-Daily Human GLP-1 Analogue Liraglutide
Kapitza, Christoph
Zdravkovic, Milan
Zijlstra, Eric
Segel, Stine
Heise, Tim
Flint, Anne
JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (06): : 951 - 955

← 1 2 3 4 5 →